Title |
Cancer Cells Retrace a Stepwise Differentiation Program during Malignant ProgressionRetracing Stepwise Differentiation During Tumor Progression
|
---|---|
Published in |
Cancer Discovery, April 2021
|
DOI | 10.1158/2159-8290.cd-20-1637 |
Pubmed ID | |
Authors |
Sadegh Saghafinia, Krisztian Homicsko, Annunziata Di Domenico, Stephan Wullschleger, Aurel Perren, Ilaria Marinoni, Giovanni Ciriello, Iacovos P. Michael, Douglas Hanahan |
X Demographics
The data shown below were collected from the profiles of 58 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 15 | 26% |
Canada | 8 | 14% |
Switzerland | 4 | 7% |
United Kingdom | 2 | 3% |
Singapore | 1 | 2% |
Germany | 1 | 2% |
Japan | 1 | 2% |
Italy | 1 | 2% |
Spain | 1 | 2% |
Other | 0 | 0% |
Unknown | 24 | 41% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 27 | 47% |
Members of the public | 24 | 41% |
Science communicators (journalists, bloggers, editors) | 4 | 7% |
Practitioners (doctors, other healthcare professionals) | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 65 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 14% |
Researcher | 7 | 11% |
Student > Bachelor | 5 | 8% |
Student > Master | 4 | 6% |
Student > Doctoral Student | 2 | 3% |
Other | 7 | 11% |
Unknown | 31 | 48% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 18 | 28% |
Medicine and Dentistry | 7 | 11% |
Immunology and Microbiology | 2 | 3% |
Agricultural and Biological Sciences | 2 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Other | 3 | 5% |
Unknown | 32 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 86. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2022.
All research outputs
#497,561
of 25,551,063 outputs
Outputs from Cancer Discovery
#253
of 4,081 outputs
Outputs of similar age
#14,247
of 454,702 outputs
Outputs of similar age from Cancer Discovery
#15
of 131 outputs
Altmetric has tracked 25,551,063 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,081 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,702 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 131 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.